{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:46:27Z","timestamp":1790113587167,"version":"4.0.1"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>This review explores the evolving understanding of vascular dysfunction in systemic sclerosis (SSc), from early endothelial injury to clinical manifestations and emerging therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Endothelial cell (EC) injury, senescence, and endothelial-to-mesenchymal transition are central to SSc vasculopathy. Single-cell and spatial omics have revealed distinct EC subtypes and dysregulated pathways, including interferon signaling and chromatin remodeling. Immune-mediated damage, viral triggers, and autoantibodies contribute to vascular pathology. Clinically, complications such as Raynaud's phenomenon, digital ulcers, pulmonary arterial hypertension, and renal crisis drive morbidity and healthcare burden. Diagnostic tools such as nailfold capillaroscopy enable early detection of microvascular changes. Novel therapies including CAR-T therapy, JAK inhibitors, and complement blockade, are under investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Vascular dysfunction is a hallmark of SSc and a key driver of disease progression. Advances in molecular profiling and imaging have improved our understanding of its mechanisms and opened new avenues for targeted intervention. Early diagnosis, biomarker-guided care, and multidisciplinary management are essential to improving outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000001126","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T11:00:57Z","timestamp":1757329257000},"page":"373-383","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Decoding vascular dysfunction in systemic sclerosis: from endothelial damage to clinical implications"],"prefix":"10.1097","volume":"37","author":[{"given":"Ryan","family":"Massay","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carleigh","family":"Zahn","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine"},{"name":"Scleroderma Program, Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Suen","family":"Tsou","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine"},{"name":"Scleroderma Program, Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"R1-20251007","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/art.41536","article-title":"Dissecting the cellular mechanism of prostacyclin analog iloprost in reversing vascular dysfunction in scleroderma","volume":"73","author":"Tsou","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R2-20251007","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1358836X0000500304","article-title":"Differential expression of nitric oxide by dermal microvascular endothelial cells from patients with scleroderma","volume":"5","author":"Romero","year":"2000","journal-title":"Vasc Med"},{"key":"R3-20251007","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3899\/jrheum.111380","article-title":"Vascular leak is a central feature in the pathogenesis of systemic sclerosis","volume":"39","author":"Frech","year":"2012","journal-title":"J Rheumatol"},{"key":"R4-20251007","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0190-9622(80)80396-3","article-title":"Capillary alterations in scleroderma","volume":"2","author":"Fleischmajer","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"R5-20251007","doi-asserted-by":"crossref","first-page":"e004290","DOI":"10.1136\/rmdopen-2024-004290","article-title":"Immunoglobulins G from patients with systemic sclerosis modify the molecular signatures of endothelial cells","volume":"11","author":"Chepy","year":"2025","journal-title":"RMD Open"},{"key":"R6-20251007","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/art.43099","article-title":"Absence of functional autoantibodies targeting angiotensin ii receptor type 1 and endothelin-1 type A receptor in circulation and purified IgG from patients with systemic sclerosis","volume":"77","author":"van Oostveen","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"R7-20251007","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10067-024-07296-6","article-title":"The predictive value of anti-IFI16 antibodies for the development or persistence of digital ulcers in systemic sclerosis","volume":"44","author":"Huang","year":"2025","journal-title":"Clin Rheumatol"},{"key":"R8-20251007","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S2665-9913(24)00282-0","article-title":"CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series","volume":"7","author":"Auth","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"R9-20251007","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1172\/JCI131700","article-title":"Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis","volume":"130","author":"Maehara","year":"2020","journal-title":"J Clin Invest"},{"key":"R10-20251007","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/rheumatology\/keae190","article-title":"Systemic sclerosis-associated pulmonary arterial hypertension is characterized by a distinct peripheral T helper cell profile","volume":"63","author":"Papadimitriou","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"R11-20251007","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13075-024-03379-6","article-title":"Elevated neutrophil extracellular traps in systemic sclerosis-associated vasculopathy and suppression by a synthetic prostacyclin analog","volume":"26","author":"Kortam","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"R12-20251007","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1099\/jgv.0.000301","article-title":"Direct infection of primary endothelial cells with human cytomegalovirus prevents angiogenesis and migration","volume":"96","author":"Gustafsson","year":"2015","journal-title":"J Gen Virol"},{"key":"R13-20251007","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1128\/JVI.79.4.2211-2220.2005","article-title":"Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation","volume":"79","author":"Rahbar","year":"2005","journal-title":"J Virol"},{"key":"R14-20251007","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/1529-0131(199902)42:2<389::AID-ANR23>3.0.CO;2-P","article-title":"Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis","volume":"42","author":"Neidhart","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R15-20251007","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3390\/v10090508","article-title":"A Paradigmatic interplay between human cytomegalovirus and host immune system: possible involvement of viral antigen-driven CD8+ T cell responses in systemic sclerosis","volume":"10","author":"Arcangeletti","year":"2018","journal-title":"Viruses"},{"key":"R16-20251007","doi-asserted-by":"crossref","first-page":"651013","DOI":"10.3389\/fimmu.2021.651013","article-title":"Innate immune modulation induced by EBV lytic infection promotes endothelial cell inflammation and vascular injury in scleroderma","volume":"12","author":"Farina","year":"2021","journal-title":"Front Immunol"},{"key":"R17-20251007","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/1756-185X.14440","article-title":"Detection of Epstein-Barr virus in systemic sclerosis patients: a molecular and serological based study","volume":"25","author":"Machhua","year":"2022","journal-title":"Int J Rheum Dis"},{"key":"R18-20251007","doi-asserted-by":"crossref","first-page":"11772719251318555","DOI":"10.1177\/11772719251318555","article-title":"Endothelin-1 as a candidate biomarker of systemic sclerosis: a GRADE-assessed systematic review and meta-analysis with meta-regression","volume":"20","author":"Mangoni","year":"2025","journal-title":"Biomark Insights"},{"key":"R19-20251007","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1113\/EP086991","article-title":"Attenuated nitric oxide bioavailability in systemic sclerosis: evidence from the novel assessment of passive leg movement","volume":"103","author":"Clifton","year":"2018","journal-title":"Exp Physiol"},{"key":"R20-20251007","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/art.41694","article-title":"Genome-wide reduction in chromatin accessibility and unique transcription factor footprints in endothelial cells and fibroblasts in scleroderma skin","volume":"73","author":"Tsou","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R21-20251007","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3389\/fimmu.2018.01383","article-title":"The role of endothelial progenitors in the repair of vascular damage in systemic sclerosis","volume":"9","author":"Del Papa","year":"2018","journal-title":"Front Immunol"},{"key":"R22-20251007","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/art.42662","article-title":"Endothelial response to type I interferon contributes to vasculopathy and fibrosis and predicts disease progression of systemic sclerosis","volume":"76","author":"Yin","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"R23-20251007","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1016\/S2665-9913(24)00403-X","article-title":"Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study","volume":"7","author":"Hinchcliff","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"R24-20251007","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1093\/rheumatology\/keae698","article-title":"Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with very early diagnosis of systemic sclerosis (VEDOSS)","volume":"64","author":"Ross","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"R25-20251007","doi-asserted-by":"crossref","first-page":"1438302","DOI":"10.3389\/fimmu.2024.1438302","article-title":"Circulating cell adhesion molecules in systemic sclerosis: a systematic review and meta-analysis","volume":"15","author":"Mangoni","year":"2024","journal-title":"Front Immunol"},{"key":"R26-20251007","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/annrheumdis-2016-210229","article-title":"Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis","volume":"76","author":"Manetti","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R27-20251007","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41467-023-44645-6","article-title":"Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis","volume":"15","author":"Ma","year":"2024","journal-title":"Nat Commun"},{"key":"R28-20251007","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCRESAHA.123.323299","article-title":"Characterization of vascular niche in systemic sclerosis by spatial proteomics","volume":"134","author":"Rius Rigau","year":"2024","journal-title":"Circ Res"},{"key":"R29-20251007","first-page":"1612","article-title":"Association of endothelial to mesenchymal transition and cellular senescence with fibrosis in skin biopsies of systemic sclerosis patients: a cross-sectional study","volume":"41","author":"Chiu","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"R30-20251007","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1093\/rheumatology\/keae660","article-title":"Dermal cellular senescence and EndMT in patients with systemic sclerosis undergoing cyclophosphamide or aHSCT treatment","volume":"64","author":"Chiu","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"R31-20251007","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.cell.2022.03.011","article-title":"LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma","volume":"185","author":"Gur","year":"2022","journal-title":"Cell"},{"key":"R32-20251007","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1136\/ard-2023-225415","article-title":"Single-cell transcriptomes and chromatin accessibility of endothelial cells unravel transcription factors associated with dysregulated angiogenesis in systemic sclerosis","author":"Huang","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"R33-20251007","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jid.2022.09.652","article-title":"Senescent cells accumulate in systemic sclerosis skin","volume":"143","author":"Shi","year":"2023","journal-title":"J Invest Dermatol"},{"key":"R34-20251007","first-page":"E84","article-title":"Endothelial cell senescence exacerbates pulmonary fibrosis potentially through accelerated endothelial to mesenchymal transition","volume":"67","author":"Ramadhiani","year":"2021","journal-title":"Kobe J Med Sci"},{"key":"R35-20251007","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41420-025-02377-0","article-title":"Endothelial senescence induced by PAI-1 promotes endometrial fibrosis","volume":"11","author":"Wu","year":"2025","journal-title":"Cell Death Discov"},{"key":"R36-20251007","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3390\/biomedicines12061331","article-title":"Recent Insights into cellular and molecular mechanisms of defective angiogenesis in systemic sclerosis","volume":"12","author":"Romano","year":"2024","journal-title":"Biomedicines"},{"issue":"(Suppl 1)","key":"R37-20251007","doi-asserted-by":"crossref","first-page":"18","DOI":"10.20452\/pamw.1487","article-title":"Very early diagnosis of systemic sclerosis","volume":"122","author":"Bellando-Randone","year":"2012","journal-title":"Pol Arch Med Wewn"},{"key":"R38-20251007","doi-asserted-by":"crossref","first-page":"101948","DOI":"10.1016\/j.berh.2024.101948","article-title":"Painful Raynaud's mimics","volume":"38","author":"Zahn","year":"2024","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R39-20251007","doi-asserted-by":"crossref","first-page":"115282","DOI":"10.1016\/j.biopha.2023.115282","article-title":"Further insight into systemic sclerosis from the vasculopathy perspective","volume":"166","author":"Ren","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R40-20251007","doi-asserted-by":"crossref","first-page":"152593","DOI":"10.1016\/j.semarthrit.2024.152593","article-title":"The pathogenesis, diagnostic utility and clinical relevance of cutaneous telangiectasia in systemic sclerosis","volume":"70","author":"Anilkumar","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"R41-20251007","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College Of Rheumatology\/European League against Rheumatism Collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R42-20251007","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.3390\/ijms25094728","article-title":"Systemic sclerosis-associated pulmonary arterial hypertension: from bedside to bench and back again","volume":"25","author":"Bahi","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R43-20251007","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.amjms.2022.02.014","article-title":"Assessment of kidney involvement in systemic sclerosis: From scleroderma renal crisis to subclinical renal vasculopathy","volume":"364","author":"Gigante","year":"2022","journal-title":"Am J Med Sci"},{"key":"R44-20251007","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4078\/jrd.2024.0129","article-title":"Pathogenesis of systemic sclerosis: an integrative review of recent advances","volume":"32","author":"Son","year":"2025","journal-title":"J Rheum Dis"},{"key":"R45-20251007","doi-asserted-by":"crossref","first-page":"152351","DOI":"10.1016\/j.anndiagpath.2024.152351","article-title":"Systemic diseases affecting the GI tract: a review of clinical and histopathologic manifestations","volume":"73","author":"Pezhouh","year":"2024","journal-title":"Ann Diagn Pathol"},{"key":"R46-20251007","doi-asserted-by":"crossref","first-page":"23247096251348903","DOI":"10.1177\/23247096251348903","article-title":"A case report and literature review on systemic sclerosis manifesting as melena and hematochezia","volume":"13","author":"El Gharib","year":"2025","journal-title":"J Investig Med High Impact Case Rep"},{"key":"R47-20251007","doi-asserted-by":"crossref","first-page":"102458","DOI":"10.1016\/j.autrev.2020.102458","article-title":"Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis","volume":"19","author":"Smith","year":"2020","journal-title":"Autoimmun Rev"},{"key":"R48-20251007","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/jamadermatol.2016.2027","article-title":"Dynamic optical coherence tomography capillaroscopy: a new imaging tool in autoimmune connective tissue disease","volume":"152","author":"Ring","year":"2016","journal-title":"JAMA Dermatol"},{"key":"R49-20251007","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00296-023-05495-z","article-title":"Peripheral and ocular microvascular alterations in systemic sclerosis: observations from capillaroscopic assessments, perfusion peripheral analysis, and optical coherence tomography angiography","volume":"44","author":"Cutolo","year":"2024","journal-title":"Rheumatol Int"},{"key":"R50-20251007","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5114\/pdia.2014.40653","article-title":"Assessment of skin microcirculation by laser Doppler flowmetry in systemic sclerosis patients","volume":"31","author":"Waszczykowska","year":"2014","journal-title":"Postepy Dermatol Alergol"},{"key":"R51-20251007","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/BOR.0000000000000901","article-title":"Imaging techniques for assessment of vascular involvement in systemic sclerosis","volume":"34","author":"Frech","year":"2022","journal-title":"Curr Opin Rheumatol"},{"key":"R52-20251007","doi-asserted-by":"crossref","first-page":"e611","DOI":"10.1016\/S2665-9913(23)00189-3","article-title":"MRI Digital Artery Volume Index (DAVIX) as a surrogate outcome measure of digital ulcer disease in patients with systemic sclerosis: a prospective cohort study","volume":"5","author":"Hughes","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"R53-20251007","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/BOR.0000000000001040","article-title":"Advances in the diagnosis of multiorgan involvement in systemic sclerosis: a focus on MRI","volume":"36","author":"Feher","year":"2024","journal-title":"Curr Opin Rheumatol"},{"key":"R54-20251007","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/ard-2024-226430","article-title":"EULAR recommendations for the treatment of systemic sclerosis: 2023 update","volume":"84","author":"Del Galdo","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"R55-20251007","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/mr\/roab117","article-title":"Efficacy of local oxygen-ozone therapy for the treatment of digital ulcer refractory to medical therapy in systemic sclerosis: a randomized controlled study","volume":"32","author":"Kaymaz","year":"2022","journal-title":"Mod Rheumatol"},{"key":"R56-20251007","doi-asserted-by":"crossref","first-page":"152256","DOI":"10.1016\/j.semarthrit.2023.152256","article-title":"Studying the role of C5-inhibition therapy in scleroderma renal crisis-induced thrombotic microangiopathy \u2212 a review of literature","volume":"63","author":"Farrukh","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"R57-20251007","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1007\/s00296-024-05689-z","article-title":"Targeting complement dysregulation: eculizumab in scleroderma renal crisis management-a case-based review","volume":"44","author":"Toker Dincer","year":"2024","journal-title":"Rheumatol Int"},{"key":"R58-20251007","doi-asserted-by":"crossref","first-page":"100753","DOI":"10.1016\/j.xkme.2023.100753","article-title":"Eculizumab use in scleroderma renal crisis with thrombotic microangiopathy: a case report","volume":"6","author":"Trivin-Avillach","year":"2024","journal-title":"Kidney Med"},{"key":"R59-20251007","doi-asserted-by":"crossref","first-page":"859330","DOI":"10.3389\/fmed.2022.859330","article-title":"JAK1\/2 inhibitor baricitinib improves skin fibrosis and digital ulcers in systemic sclerosis","volume":"9","author":"Hou","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R60-20251007","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1007\/s10067-025-07433-9","article-title":"BAricitinib in patients with SystemIC Sclerosis (BASICS): a prospective, open-label, randomised trial","volume":"44","author":"Chen","year":"2025","journal-title":"Clin Rheumatol"},{"key":"R61-20251007","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/ard-2023-223952","article-title":"Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells","volume":"82","author":"Bergmann","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R62-20251007","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1016\/j.cell.2024.06.027","article-title":"Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"key":"R63-20251007","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/ard-2023-225174","article-title":"Third-generation CD19.CAR-T cell-containing combination therapy in Scl70+ systemic sclerosis","volume":"83","author":"Merkt","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"R64-20251007","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1093\/rheumatology\/keaf077","article-title":"Targeting autoimmunity with CD19-CAR T-cell therapy: efficacy and seroconversion in diffuse systemic sclerosis and rheumatoid arthritis","volume":"64","author":"Albach","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"R65-20251007","doi-asserted-by":"crossref","first-page":"114071","DOI":"10.1016\/j.ejca.2024.114071","article-title":"Application of blinatumomab, a bispecific anti-CD3\/CD19 T-cell engager, in treating severe systemic sclerosis: a case study","volume":"204","author":"Subklewe","year":"2024","journal-title":"Eur J Cancer"},{"key":"R66-20251007","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/acr2.11616","article-title":"Economic and healthcare resource use burden of systemic sclerosis","volume":"5","author":"Khanna","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"R67-20251007","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.rdc.2023.01.004","article-title":"Treatment of vascular complications in systemic sclerosis: what is the best approach to diagnosis and management of renal crisis and digital ulcers?","volume":"49","author":"Hughes","year":"2023","journal-title":"Rheum Dis Clin North Am"},{"key":"R68-20251007","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/jdv.15114","article-title":"Increased risk of mortality in systemic sclerosis-associated digital ulcers: a systematic review and meta-analysis","volume":"33","author":"Meunier","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R69-20251007","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s13075-019-2080-y","article-title":"Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden","volume":"21","author":"Morrisroe","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"R70-20251007","first-page":"1516","article-title":"The burden of illness of the organ manifestations of systemic sclerosis: a pragmatic, targeted review","volume":"43","author":"Smith","year":"2025","journal-title":"Clin Exp Rheumatol"},{"key":"R71-20251007","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s12016-022-08946-w","article-title":"Systemic sclerosis-specific antibodies: novel and classical biomarkers","volume":"64","author":"Cavazzana","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"R72-20251007","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/rheumatology\/keac614","article-title":"Association between anti-SSSCA1 antibodies and cancer in systemic sclerosis","volume":"62","author":"Wallwork","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"R73-20251007","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/ard-2024-225596","article-title":"Identification and validation of antiprotein arginine methyltransferase 5 (PRMT5) antibody as a novel biomarker for systemic sclerosis (SSc)","volume":"83","author":"Liang","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"R74-20251007","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.medcli.2023.11.020","article-title":"Prognostic value of anti-IFI16 autoantibodies in pulmonary arterial hypertension and mortality in patients with systemic sclerosis","volume":"162","author":"Perurena-Prieto","year":"2024","journal-title":"Med Clin (Barc)"},{"key":"R75-20251007","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s42358-020-00140-w","article-title":"Antiannexin V autoantibodies and vascular abnormalities in systemic sclerosis: a longitudinal study","volume":"60","author":"Horimoto","year":"2020","journal-title":"Adv Rheumatol"},{"key":"R76-20251007","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1002\/acr.25118","article-title":"Antivinculin antibodies in systemic sclerosis: associations with slow gastric transit and extraintestinal clinical phenotype","volume":"75","author":"Herr\u00e1n","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R77-20251007","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1007\/s10067-022-06301-0","article-title":"Antivinculin antibodies as a novel biomarker in Egyptian patients with systemic sclerosis","volume":"41","author":"Ibrahim","year":"2022","journal-title":"Clin Rheumatol"},{"key":"R78-20251007","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/art.42667","article-title":"Anti-gephyrin antibodies: a novel specificity in patients with systemic sclerosis and lower bowel dysfunction","volume":"76","author":"McMahan","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"R79-20251007","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/ard-2022-223237","article-title":"Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis","volume":"82","author":"Sanges","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R80-20251007","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/acr.25344","article-title":"Serum CCL24 as a biomarker of fibrotic and vascular disease severity in systemic sclerosis","volume":"76","author":"De Lorenzis","year":"2024","journal-title":"Arthritis Care Res"},{"key":"R81-20251007","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/acr.25180","article-title":"Endothelial biomarkers of systemic sclerosis-associated pulmonary hypertension","volume":"77","author":"Lammi","year":"2025","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R82-20251007","doi-asserted-by":"crossref","first-page":"1450176","DOI":"10.3389\/fimmu.2024.1450176","article-title":"Endostatin as a biomarker of systemic sclerosis: insights from a systematic review and meta-analysis","volume":"15","author":"Mangoni","year":"2024","journal-title":"Front Immunol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T05:00:57Z","timestamp":1759813257000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001126","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]}}}